Novel indications for DCB

Session comprising selected EuroPCR 2026 abstract submissions

Summary

This session reviews emerging clinical applications for drug-coated balloons (DCB) beyond traditional indications. It covers outcomes in venous stenosis, aorto-ostial lesions, and coronary bifurcation disease, comparing DCB strategies with drug-eluting stents and highlighting recent clinical trial findings.

Presentations available when logged in:

  • Clinical outcomes of DCB venoplasty in lead-related venous stenosis
  • Long term outcomes of de novo aorto-ostial lesions with DCB compared to DES: a retrospective analysis
  • SELUTION DeNovo: sirolimus DEB with provisional stenting vs. systematic DES in de novo lesions
  • DCB strategies in coronary bifurcation lesions: beyond side-branch treatment
  • Real-world comparison of DCB and stent for main vessel in bifurcation lesions
  • DCB vs. DES for treating Medina 0.0.1 bifurcation lesions: a comparative analysis
  • LOVE-DEB study: 12-month outcome of the safety and efficacy of sirolimus eluting DEB in de novo coronary lesions in large vessels